The impact of diagnostic criteria for neuromyelitis optica in patients with MS: A 10-year follow-up of the South Atlantic Project

Multiple Sclerosis Journal

Volumn 20, Issue 3, 2014, Pages 374-381

  Papais Alvarenga, Regina M ^a,b   Vasconcelos, Claudia C F ^b   Alves Leon, Soniza V ^b,c   Batista, Elizabeth ^a   Santos, Claudia M M ^b   Camargo, Solange M G G ^a   Godoy, Mauricio ^d   Lacativa, Maria C ^b,e   Lorenti, Mariangela ^e   Damasceno, Benito ^f   Damasceno, Alfredo ^f   Brum, Doralina ^g   Barreira, Amilton A ^h   Guimarães Rocha, Maria S ⁱ   Alvarenga, Helcio ^b   Tilbery, Charles P ^j  

^a HOSPITAL DA LAGOA   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^e HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

^f UNIVERSITY OF CAMPINAS   (Brazil)

^g Department of Neurology Faculdade de Botucatu   (Brazil)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ HOSPITAL SANTA MARCELINA   (Brazil)

^j Hospital Santa Marcelina ^*  (Brazil)

more..

Author keywords

Brasil; demyelination; encephalomyelitis; epidemiology; ethnicity; inflammation; multiple sclerosis; neuromyelitis optica; primary progressive multiple sclerosis; relapsing remitting multiple sclerosis

Indexed keywords

ACUTE BRAIN DISEASE; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BRAZIL; CAUCASIAN; CHILD; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; DISEASE DURATION; ETHNIC DIFFERENCE; ETHNICITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEGRO; ONSET AGE; POPULATION RESEARCH; RELAPSE; REMISSION; SOUTH AND CENTRAL AMERICA; BRAIN BIOPSY; BRAIN DAMAGE; DISABILITY SEVERITY; DISEASE ASSOCIATION; MEDICAL RECORD REVIEW; MORTALITY; RACE DIFFERENCE; SEX DIFFERENCE;

BRASIL; DEMYELINATION; ENCEPHALOMYELITIS; EPIDEMIOLOGY; ETHNICITY; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; RELAPSING-REMITTING MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; YOUNG ADULT;

EID: 84895428073     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513495580     Document Type: Article

References (31)

1. Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 14 (1996). 291-308
2. Wingerchuk DW, Weinshenker BG Raine CS, McFarland HF, Hohlfeld R Multiple sclerosis: a comprehensive text. Philadelphia: Saunders Elsevier ; 2008 :
3. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
4. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria.". Ann Neurol. 2005 ; 58: 840-846 (Pubitemid 41746873)
5. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2010 ; 69: 292-302
6. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008 ; 14: 1157-1174
7. Mandler RN, Davis LE, Jeffery DR, et al. Devic's neuromyelitis optica: A clinicopathological study of 8 patients. Ann Neurol. 1993 ; 34: 162-168 (Pubitemid 23223043)
8. Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry. 1996 ; 60: 382-387 (Pubitemid 26118744)
9. Wingerchuk DM, Hogancamp WF, O'Brien PC, et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999 ; 53: 1107-1114 (Pubitemid 29442132)
10. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry. 2002 ; 73: 429-435
11. De Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: Clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002 ; 197: 57-61 (Pubitemid 34462145)
12. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
13. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2002 ; 364: 2106-2112 (Pubitemid 39626806)
14. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005 ; 202: 473-477 (Pubitemid 41186945)
15. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003 ; 2: 117-127 (Pubitemid 37443332)
16. Cabre P, Gonzalez-Quevedo A, Lannuzel A, et al. Descriptive epidemiology of neuromyelitis optica in the Caribbean Basin. Rev Neurol. 2002 ; 165: 676-683
17. Cabrera-Gomez JA, Kurtzke JF, Gonzalez-Quevedo A, et al. An epidemiological study of neuromyelitis optica in Cuba. J Neurol. 2009 ; 256: 35-44
18. Asgari N, Lillevang ST, Skejoe HPB, et al. A population-based study of neuromyelitis optica in Caucasians. Neurology. 2011 ; 76: 1589-1595
19. Cossburn M, Tackley G, Baker K, et al. The prevalence of neuromyelitis optica in South East Wales. Eur J Neurol Eur J Neurol. 2011 2012 ; 19: 655-659
20. Cabre P, Heinzlef O, Merle H, et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 2001 ; 56: 507-514 (Pubitemid 32172877)
21. Rivera JF, Kurtzke JF, Booth VJ, et al. Characteristics of Devic's disease (neuromyelitis optica) in Mexico. J Neurol. 2008 ; 255: 710-715
22. Wu JS, Zhang MN, Carroll WM, et al. Characterization of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry. 2008 ; 79: 1022-1026
23. Bizzoco E, Lolli F, Repice AM, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol. 2009 ; 256: 1891-1898
24. Papais-Alvarenga RM, Leon Alves S, Tilbery CP, et al Esclerosis multipla - Una mirada Ibero Latino Americana. Nogales-Gaete CARJ, ed. New York: DEMOS ; 2002: 35-45.
25. Papais-Alvarenga RM, Leon Alves S, Tilbery CP, et al. SIAPEM: a Brazilian software database for multiple sclerosis research in tropical countries. African J Neurol Sci. 2003 ;:
26. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
27. Corona T, Roman GC. Multiple sclerosis in Latin America. Neuroepidemiol. 2006 ; 26: 1-3 (Pubitemid 41797931)
28. Melcolm Cristiano E, Patrucco L, Rojas JI. A systematic review of the epidemiology of multiple sclerosis in South America. Eur J Neurol. 2008 ; 15: 1273-1278
29. Asgari N, Owens T, Frokiaer J, et al. Neuromyelitis optica (NMO), an autoimmune disease of the central nervous system (CNS). Acta Neurol Scand. 2011 ; 123: 369-384
30. Collongues N, De Seze J. Current and future treatment approaches for neuromyelitis optica. Adv Neurol Disord. 2011 ; 4: 111-121
31. Rubiera M, Rio J, Tintore M, et al. Neuromyelitis optica diagnosis in clinically isolated syndrome is suggestive of multiple sclerosis. Neurology. 2006 ; 66: 1568-1570 (Pubitemid 43958558)